What is the official website of Grifols Biopharma ?

The official website of Grifols Biopharma is https://www.biosuppliesproducts.com/en/home.

What is Grifols Biopharma's cybersecurity risk score?

Grifols Biopharma has an AI-generated cybersecurity risk score of 844 out of 1000, indicating a Good security posture according to Rankiteo's assessment.

How many security incidents has Grifols Biopharma experienced?

According to Rankiteo, Grifols Biopharma currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Grifols Biopharma been affected by any supply chain cyber incidents ?

According to Rankiteo, Grifols Biopharma has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Grifols Biopharma have SOC 2 Type 1 certification ?

According to Rankiteo, Grifols Biopharma is not certified under SOC 2 Type 1.

Does Grifols Biopharma have SOC 2 Type 2 certification ?

According to Rankiteo, Grifols Biopharma does not hold a SOC 2 Type 2 certification.

Does Grifols Biopharma comply with GDPR ?

According to Rankiteo, Grifols Biopharma is not listed as GDPR compliant.

Does Grifols Biopharma have PCI DSS certification ?

According to Rankiteo, Grifols Biopharma does not currently maintain PCI DSS compliance.

Does Grifols Biopharma comply with HIPAA ?

According to Rankiteo, Grifols Biopharma is not compliant with HIPAA regulations.

Does Grifols Biopharma have ISO 27001 certification ?

According to Rankiteo,Grifols Biopharma is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Grifols Biopharma operate in ?

Grifols Biopharma operates primarily in the Fabricación de productos farmacéuticos industry.

How many employees does Grifols Biopharma have ?

Grifols Biopharma employs approximately 6 people worldwide.

Does Grifols Biopharma own any subsidiaries ?

Grifols Biopharma presently has no subsidiaries across any sectors.

How many LinkedIn followers does Grifols Biopharma have ?

Grifols Biopharma's official LinkedIn profile has approximately 817,412,400 followers.

Does Grifols Biopharma have a Crunchbase profile ?

No, Grifols Biopharma does not have a profile on Crunchbase.

Does Grifols Biopharma have a LinkedIn profile ?

Yes, Grifols Biopharma maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/grifols-biopharma.

How many cybersecurity incidents has Grifols Biopharma experienced ?

As of September 23, 2026, Rankiteo reports that Grifols Biopharma has not experienced any cybersecurity incidents.

How many peer or competitor companies does Grifols Biopharma have ?

Grifols Biopharma has an estimated 2 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Grifols Biopharma

Boost Score +25 with badge (5 left)

844

/1000

Good

869

/1000

Very Good

Grifols Biopharma Vendor Cyber Rating & Cyber Score

https://www.biosuppliesproducts.com/en/home

Add Your Compliance Badge

Grifols Biopharma Division is a leading producer of plasma-derived biological medicines for the treatment of rare, chronic, and sometimes life-threatening conditions.

Grifols Biopharma

Grifols Biopharma CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Grifols Biopharma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Grifols Biopharma

Incidents vs Fabricación de productos farmacéuticos Industry Avg (This Year)

No incidents recorded for Grifols Biopharma in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Grifols Biopharma in 2026.

Incident Types Grifols Biopharma vs Fabricación de productos farmacéuticos Industry Avg (This Year)

No incidents recorded for Grifols Biopharma in 2026.

Incident History - Grifols Biopharma (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Grifols Biopharma Subsidiaries

Grifols Biopharma

Fabricación de productos farmacéuticos

Website: https://www.biosuppliesproducts.com/en/home

Company Size: 6

Grifols DiagnosticFabricación de equipo médico

GrifolsPharmaceutical Manufacturing

Grifols Bio SuppliesBiotechnology Research

Grifols Healthcare SolutionsHospitales y atención sanitaria

Loading…

Grifols Biopharma Similar Companies

Loading…

NEWS

Grifols Biopharma CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

April 02, 2025 07:00 AM

Spanish pharma company Grifols' shares up on Brookfield talk

Shares in Spanish pharmaceutical company Grifols rose on Wednesday after Canadian fund Brookfield said it was talking with shareholders,...

Read Article

May 24, 2024 07:00 AM

Cencora data breach exposes patient data at top pharma firms

The Cencora breach affected some of the most prominent Big Pharma firms, including Novartis, Bayer, AbbVie, Regeneron, Genentech and Incyte.

Read Article

April 18, 2024 07:00 AM

Grifols celebrates 50 years in Johnston County as area continues to embrace biotech

Grifols is one of multiple biopharma companies in Johnston County. It's a county that was known for agriculture but now is quickly becoming...

Read Article

February 21, 2023 08:00 AM

Executive chairman of Spanish pharma company Grifols resigns

Steven F. Mayer has resigned as executive chairman of the board of Spanish pharmaceutical company Grifols , the company said on Tuesday,...

Read Article

July 21, 2020 07:00 AM

Grifols to acquire GC Pharma’s plasma fractionation facility for $460m

Grifols has executed purchase arrangements with the South Korean-based GC Pharma to acquire a plasma fractionation facility in Montreal, Canada for $460m.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-95828

SUMMARY

A vulnerability was determined in Mstfakts College-Management-System. This affects the function session_start of the file Front-end/server.php of the component Authentication. Executing a manipulation can lead to session fixiation. It is possible to launch the attack remotely. The exploit has been publicly disclosed and may be utilized. This product takes the approach of rolling releases to provide continious delivery. Therefore, version details for affected and updated releases are not available. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-95820

SUMMARY

A vulnerability was found in anirbandutta9 College-Notes-Gallery up to 8c1cf3d98f30982d069c88ca172612c001eb39f6. Affected by this issue is some unknown functionality of the file /dashboard/userprofile.php?section=admin1. Performing a manipulation of the argument image results in unrestricted upload. It is possible to initiate the attack remotely. The exploit has been made public and could be used. This product is using a rolling release to provide continious delivery. Therefore, no version details for affected nor updated releases are available. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-61685

SUMMARY

ReactPress is a publishing system for React developers. Prior to version 3.7.0, ReactPress API list endpoints build TypeORM `QueryBuilder` conditions using unsanitized HTTP query parameter names as SQL column identifiers (e.g. `` `article.${key}` ``). TypeORM parameterizes values but not column names, allowing unauthenticated attackers to inject SQL through crafted query string keys. Version 3.7.0 contains a patch. As a workaround, allowlist allowed filter column names before interpolating into SQL.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-57576

SUMMARY

plone.app.dexterity is a content-type system for the Plone content management system, and plone.app.contenttypes provides Plone’s Dexterity-based content types. Plone.app.dexterity versions through 3.2.2, 4.0.0 through 4.1.2, and 5.0.0, and plone.app.contenttypes versions through 3.0.11, 4.0.0 through 4.0.9, and 5.0.0 are vulnerable to denial of service because an authenticated user can create content with excessively long titles, descriptions, or uploaded-file names, causing Plone to become unresponsive and potentially making the resulting content difficult to edit or delete. The vulnerability is patched in plone.app.dexterity versions 3.2.3, 4.1.3, and 5.0.1, and in plone.app.contenttypes versions 3.0.12, 4.0.10, and 5.0.1.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

CVE-2026-18176

SUMMARY

IBM Financial Transaction Manager (FTM) for RedHat OpenShift could allow a remote attacker to obtain sensitive information due to cleartext transmission of sensitive information.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N

Impact Score

Exploitability

2.8

REFERENCES

https://www.ibm.com/support/pages/node/7288641

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Grifols Biopharma Vendor Cyber Rating & Cyber Score

Grifols Biopharma A.I CyberSecurity Scoring

Grifols Biopharma CyberSecurity News & History

Grifols Biopharma Company Scoring based on AI Models